Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3316)
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
1,300
Price
$49.98
Total Value
$64.97K
Shares Held After
97,994
% of Holdings
1.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
6,200
Price
$49.21
Total Value
$305.10K
Shares Held After
99,294
% of Holdings
5.9%
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
7,958
Price
$50.00
Total Value
$397.90K
Shares Held After
0
% of Holdings
100.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,656
Price
$49.92
Total Value
$132.59K
Shares Held After
627,540
% of Holdings
0.4%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
12,344
Price
$49.20
Total Value
$607.32K
Shares Held After
630,196
% of Holdings
1.9%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
100
Price
$85.89
Total Value
$8.59K
Shares Held After
208,398
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
2,702
Price
$85.33
Total Value
$230.56K
Shares Held After
208,498
% of Holdings
1.3%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
2,698
Price
$84.31
Total Value
$227.47K
Shares Held After
211,200
% of Holdings
1.3%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
1,100
Price
$85.46
Total Value
$94.01K
Shares Held After
177,371
% of Holdings
0.6%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
900
Price
$84.46
Total Value
$76.01K
Shares Held After
178,471
% of Holdings
0.5%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
40
Price
$779.71
Total Value
$31.19K
Shares Held After
17,603
% of Holdings
0.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
4
Price
$778.24
Total Value
$3.11K
Shares Held After
17,643
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
9
Price
$777.42
Total Value
$7.00K
Shares Held After
17,647
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
13
Price
$776.62
Total Value
$10.10K
Shares Held After
17,656
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
14
Price
$775.58
Total Value
$10.86K
Shares Held After
17,669
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
8
Price
$774.58
Total Value
$6.20K
Shares Held After
17,683
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
8
Price
$773.59
Total Value
$6.19K
Shares Held After
17,691
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
3
Price
$772.76
Total Value
$2.32K
Shares Held After
17,699
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
1
Price
$771.32
Total Value
$771.32
Shares Held After
17,702
% of Holdings
0.0%
BioAge Labs, Inc. (BIOA)
RUBIN PAUL D — Chief Medical Officer
Shares
8,820
Price
$17.81
Total Value
$157.08K
Shares Held After
0
% of Holdings
100.0%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
838
Price
$58.93
Total Value
$49.39K
Shares Held After
162,994
% of Holdings
0.5%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
1,412
Price
$58.14
Total Value
$82.09K
Shares Held After
165,406
% of Holdings
0.8%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
62,344
Price
$164.95
Total Value
$10.28M
Shares Held After
106,810
% of Holdings
36.9%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
19,001
Price
$164.11
Total Value
$3.12M
Shares Held After
169,154
% of Holdings
10.1%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
6,715
Price
$163.18
Total Value
$1.10M
Shares Held After
188,155
% of Holdings
3.4%
Dyne Therapeutics, Inc. (DYN)
Lucera Erick — Chief Financial Officer
Shares
5,727
Price
$18.64
Total Value
$106.75K
Shares Held After
125,373
% of Holdings
4.4%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
1,838
Price
$32.66
Total Value
$60.03K
Shares Held After
38,864
% of Holdings
4.5%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
80
Price
$70.30
Total Value
$5.62K
Shares Held After
60,137
% of Holdings
0.1%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
12,530
Price
$69.50
Total Value
$870.84K
Shares Held After
60,217
% of Holdings
17.2%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
39,393
Price
$68.89
Total Value
$2.71M
Shares Held After
72,747
% of Holdings
35.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
10,000
Price
$23.88
Total Value
$238.80K
Shares Held After
39,744
% of Holdings
20.1%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,667
Price
$5.99
Total Value
$99.86K
Shares Held After
1,209,840
% of Holdings
1.4%
Tectonic Therapeutic, Inc. (TECX)
Ruddy Marcella K. — Chief Medical Officer
Shares
1,000
Price
$31.05
Total Value
$31.05K
Shares Held After
68,747
% of Holdings
1.4%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Liu Joy — EVP and Chief Legal Officer
Shares
978
Price
$449.17
Total Value
$439.29K
Shares Held After
21,833
% of Holdings
4.3%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
24
Price
$191.74
Total Value
$4.60K
Shares Held After
384,682
% of Holdings
0.0%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
2,292
Price
$190.94
Total Value
$437.63K
Shares Held After
384,706
% of Holdings
0.6%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
3,684
Price
$190.22
Total Value
$700.78K
Shares Held After
386,998
% of Holdings
0.9%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
2,469
Price
$106.18
Total Value
$262.16K
Shares Held After
85,533
% of Holdings
2.8%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
5,417
Price
$105.30
Total Value
$570.41K
Shares Held After
88,002
% of Holdings
5.8%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
3,544
Price
$104.39
Total Value
$369.96K
Shares Held After
93,419
% of Holdings
3.7%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
679
Price
$16.00
Total Value
$10.86K
Shares Held After
3,622
% of Holdings
15.8%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
7,479
Price
$16.83
Total Value
$125.84K
Shares Held After
25,318
% of Holdings
22.8%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
500
Price
$15.86
Total Value
$7.93K
Shares Held After
32,797
% of Holdings
1.5%
Neuraxis, INC (NRXS)
Henrichs Timothy Robert — Chief Financial Officer
Shares
7,593
Price
$1.96
Total Value
$14.88K
Shares Held After
7,593
% of Holdings
100.0%
Neuraxis, INC (NRXS)
Carrico Thomas Joeseph — CRO, CCO, CPO
Shares
667
Price
$1.96
Total Value
$1.31K
Shares Held After
331,903
% of Holdings
0.2%
Neuraxis, INC (NRXS)
Carrico Brian Allen — Director
Shares
8,060
Price
$1.96
Total Value
$15.80K
Shares Held After
348,178
% of Holdings
2.3%
Erasca, Inc. (ERAS)
Garner Ebun — Chief Legal Officer
Shares
80,000
Price
$16.40
Total Value
$1.31M
Shares Held After
25,076
% of Holdings
76.1%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
3,500
Price
$2.20
Total Value
$7.70K
Shares Held After
29,375
% of Holdings
10.6%
COMPUGEN LTD (CGEN)
Ophir Eran — Director
Shares
5,625
Price
$2.21
Total Value
$12.41K
Shares Held After
11,375
% of Holdings
33.1%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
300
Price
$30.34
Total Value
$9.10K
Shares Held After
12,965
% of Holdings
2.3%
Showing 251–300 of 3316 transactions (page 6 of 67)